scholarly journals Association of severe myoclonic epilepsy of infancy (SMEI) with probable autoimmune lymphoproliferative syndrome-variant

2014 ◽  
Vol 36 (5-6) ◽  
Author(s):  
A. Berio ◽  
G. Mangiante ◽  
A. Piazzi

The paper reported on a case of severe myoclonic epilepsy of infancy (SMEI) associated with a probable autoimmune lymphoproliferative syndrome variant (Dianzani autoimmune lymphoproliferative disease) (DALD). A male patient with typical features of SMEI and a SCN1A gene variant presented in the first year of life with multiple lymph nodes, palpable liver at 2 cm from the costal margin, neutropenia, dysgammaglobulinemia, relative and sometimes absolute lymphocytosis. Subsequently the patient presented with constantly raised IgA in serum and positive antinuclear and thyroid antimicrosomal antibodies. The diagnosis of probable autoimmune lymphoproliferative syndrome was made; arthritis, skin and throat blisters, which appeared subsequently led to the diagnosis of linear IgA disease. On the basis of these unique associations, the Authors hypothesized that autoimmunity may be partly responsible of the severe epileptic symptomatology, perhaps mediated by autoantibodies against sodium channels or by accompanying cytotoxic T-lymphocytes. Corticosteroid treatment ameliorated the epilepsy and laboratory tests. Future studies will be necessary to evaluate the relevance of autoimmunity in SMEI.

2003 ◽  
Vol 21 (6) ◽  
pp. 615-621 ◽  
Author(s):  
Lieve Claes ◽  
Berten Ceulemans ◽  
Dominique Audenaert ◽  
Katrien Smets ◽  
Ann Löfgren ◽  
...  

Epilepsia ◽  
2001 ◽  
Vol 42 (7) ◽  
pp. 837-844 ◽  
Author(s):  
R. Singh ◽  
E. Andermann ◽  
W. P. A. Whitehouse ◽  
A. S. Harvey ◽  
D. L. Keene ◽  
...  

2017 ◽  
Vol 32 (5) ◽  
pp. 494-498 ◽  
Author(s):  
Stephen P. Fulton ◽  
Kate Van Poppel ◽  
Amy L. McGregor ◽  
Basanagoud Mudigoudar ◽  
James W. Wheless

Mutations in the SCN1A gene cause a spectrum of epilepsy syndromes. There are 2 syndromes that are on the severe end of this spectrum. The classic severe form, Dravet syndrome, is an epileptic encephalopathy of childhood, causing cognitive decline as well as intractable seizures. Severe Myoclonic Epilepsy of Infancy–Borderline (SMEIB) is a term used to include cases with similar severities as those with Dravet syndrome, but lacking a single feature of classic severe myoclonic epilepsy of infancy. Vagus nerve stimulation is a nonpharmacologic treatment for intractable epilepsy. A retrospective review was conducted of patients with deleterious SCN1A mutations who had vagus nerve stimulation placement for treatment of their intractable epilepsy. These children had onset of their epilepsy between 3 and 29 months of age. Seizure control was assessed 6 months after implantation. Twenty patients are included in the study, with 12 implanted at our institution. Nine of the 12 patients implanted at our institution, who had confirmed pre- and post-implantation seizure assessments, showed improvement in seizure control, which was defined as >50% reduction in generalized tonic-clonic seizures, and 4 of those 12 reported improvement in cognitive or speech development. Seven of the 8 patients not implanted at our institution reported subjective benefit, with 4 relating “marked improvement” or seizure freedom. Vagus nerve stimulation appears to impart a benefit to children with deleterious SCN1A gene abnormalities associated with intractable epilepsy.


Neurology ◽  
2007 ◽  
Vol 69 (3) ◽  
pp. 250-254 ◽  
Author(s):  
P. Striano ◽  
A. Coppola ◽  
M. Pezzella ◽  
C. Ciampa ◽  
N. Specchio ◽  
...  

2003 ◽  
Vol 53 (3) ◽  
pp. 196-200 ◽  
Author(s):  
Francesca Madia ◽  
Elena Gennaro ◽  
Massimiliano Cecconi ◽  
Daniela Buti ◽  
Giuseppe Capovilla ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document